We are live on ! Find out more
AIM

ARK Investment Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 64.92%
 

ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.

This Fund
S&P 500
This Quarter Est. Return
+42.62%
1 Year Est. Return
+64.92%
3 Year Est. Return
+195.95%
5 Year Est. Return
+58.35%
10 Year Est. Return
AUM
$37.6B
AUM Growth
+$20.7B
Cap. Flow
+$13B
Cap. Flow %
34.65%
Top 10 Hldgs %
36.92%
Holding
249
New
26
Increased
191
Reduced
25
Closed
5

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$1.18B
2
EXAS
Exact Sciences
EXAS
+$578M
3
SHOP icon
Shopify
SHOP
+$505M
4
PYPL icon
PayPal
PYPL
+$489M
5
BEKE icon
KE Holdings
BEKE
+$441M

Sector Composition

Rank Sector Weight
1 Healthcare 32.82%
2 Technology 23.95%
3 Communication Services 14.69%
4 Consumer Discretionary 10.63%
5 Financials 4.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCT icon
51
Arcturus Therapeutics
ARCT
$211M
$172M 0.46%
3,959,019
+1,463,177
+59% +$99.1M
SNAP icon
52
Snap
SNAP
$9.01B
$166M 0.44%
3,323,503
+702,111
+27% +$29.2M
GOOGL icon
53
Alphabet (Google) Class A
GOOGL
$4.33T
$165M 0.44%
+1,882,200
New +$158M
TAK icon
54
Takeda Pharmaceutical
TAK
$55.7B
$157M 0.42%
8,618,165
+7,461,868
+645% +$131M
INCY icon
55
Incyte
INCY
$24.4B
$155M 0.41%
1,782,380
+1,203,054
+208% +$104M
JD icon
56
JD.com
JD
$44.5B
$144M 0.38%
1,637,783
+945,079
+136% +$78.9M
CSTL icon
57
Castle Biosciences
CSTL
$979M
$139M 0.37%
2,068,592
+1,620,867
+362% +$87.9M
IONS icon
58
Ionis Pharmaceuticals
IONS
$9.4B
$136M 0.36%
2,399,554
+1,896,994
+377% +$94.5M
CELL
59
DELISTED
PhenomeX Inc. Common Stock
CELL
$131M 0.35%
1,464,517
+1,378,185
+1,596% +$116M
BABA icon
60
Alibaba
BABA
$308B
$125M 0.33%
537,424
+280,052
+109% +$77.8M
AAPL icon
61
Apple
AAPL
$4.57T
$121M 0.32%
914,900
+684,976
+298% +$82.4M
NFLX icon
62
Netflix
NFLX
$309B
$112M 0.3%
2,064,180
+1,219,790
+144% +$61.8M
SDGR icon
63
Schrodinger
SDGR
$1.36B
$110M 0.29%
1,395,453
+878,418
+170% +$55.2M
ACCD
64
DELISTED
Accolade Inc
ACCD
$103M 0.27%
2,368,304
+1,774,720
+299% +$78.8M
FSLY icon
65
Fastly Inc
FSLY
$3.66B
$99.5M 0.26%
+1,138,656
New +$100M
CRM icon
66
Salesforce
CRM
$158B
$99.4M 0.26%
446,604
+301,960
+209% +$73.4M
SYRS
67
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$98.1M 0.26%
904,132
-217,119
-19% -$19.8M
NVDA icon
68
NVIDIA
NVDA
$5.42T
$95.4M 0.25%
7,304,240
+3,813,680
+109% +$51.1M
BEAM icon
69
Beam Therapeutics
BEAM
$2.84B
$92.4M 0.25%
+1,131,623
New +$55.6M
ADPT icon
70
Adaptive Biotechnologies
ADPT
$3.97B
$91.4M 0.24%
1,545,703
+660,981
+75% +$34.1M
OPEN icon
71
Opendoor
OPEN
$3.38B
$90.9M 0.24%
4,134,600
+3,928,228
+1,903% +$82.4M
TMO icon
72
Thermo Fisher Scientific
TMO
$220B
$88.6M 0.24%
190,269
+190,192
+247,003% +$89.2M
CDXS icon
73
Codexis
CDXS
$158M
$86.5M 0.23%
3,962,106
+2,549,807
+181% +$42M
VEEV icon
74
Veeva Systems
VEEV
$37.4B
$82.4M 0.22%
+302,629
New +$84.8M
HAPN
75
Happen Inc
HAPN
$2.24B
$78.7M 0.21%
7,455,162
-32,689
-0.4% -$219K

Similar funds

ARK Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, ARK Investment Management held 249 positions worth $37.6B, up 123% from $16.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

ARK Investment Management deployed $13B of net new capital in Q4 2020, opening 26 new positions and adding to 191 existing holdings. Its largest new stake was KE Holdings: 6,638,093 shares worth $409M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Slack Technologies, Inc., an estimated $437M trimmed.

  • ARK Investment Management's largest Q4 2020 buy was KE Holdings: 6,638,093 shares worth $409M.
  • ARK Investment Management added most to Teladoc Health in Q4 2020, an estimated $1.18B increase.
  • ARK Investment Management's biggest Q4 2020 reduction was Slack Technologies, Inc., cutting an estimated $437M.
  • ARK Investment Management fully exited Twitter, Inc. in Q4 2020, selling an estimated $29.6M.
  • ARK Investment Management's ten largest holdings make up 37% of its $37.6B portfolio in Q4 2020.
  • ARK Investment Management opened 26 new positions and closed 5 in Q4 2020.
  • ARK Investment Management's portfolio value rose 123% quarter-over-quarter to $37.6B.

Based on ARK Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.